Resources from the same session
Biomarker guided strategy
Presenter: N. Klümper, DE
Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC
Resources:
Slides
Webcast
Surgeon point of view: Assessing the risk of relapse
Presenter: A. Bex, NL
Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC
Resources:
Slides
Webcast
Patient’s advocate point of view
Presenter: K. Kastrati, DE
Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC
Resources:
Slides
Webcast
Treatment after progression on adjuvant therapy in renal and bladder cancer
Presenter: U. Vogl, CH
Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC
Resources:
Slides
Webcast
Participants clinical case discussion: Metastasectomy in renal cancer treated with immunotherapy
Presenter: E. Bagiokou, GR
Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC
Resources:
Slides
Webcast
Participants clinical case discussion: A hole in one with pembrolizumab
Presenter: M. Bienz, UK
Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC
Resources:
Slides
Webcast
Participants clinical case discussion: Neoadjuvant treatment for small-cell cancer of the bladder and late paraneoplastic problems
Presenter: A.M. Schmitt, CH
Session: SESSION 4 - Debate around adjuvant therapy for Bladder and RCC
Resources:
Slides
Webcast